In 2023, CMS held listening sessions for stakeholders to offer feedback on the first ten drugs selected for the Medicare Drug Price Negotiation Program. However, the meeting structure prevented CMS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results